OncoSec Medical Inc (ONCSQ)

[$Moneypenny$]

So, how is that different with the human trials? The systemic effects have always been a noted side effect of the trials. I especially don't understand the significance of this study when ONCS has already announced that it plans on doing a combination study with PD-1's. I probably sound dumb here, but I still don't understand why this study matters. I thought they were going to do a combination with anti PD-1 and report results. Am I totally out to lunch here?